Karyopharm Theraps Company Profile

What is the competitive landscape for KARYOPHARM THERAPS, and what generic alternatives to KARYOPHARM THERAPS drugs are available?

KARYOPHARM THERAPS has one approved drug.

There are six US patents protecting KARYOPHARM THERAPS drugs.

There are one hundred patent family members on KARYOPHARM THERAPS drugs in thirty-six countries and eight supplementary protection certificates in eight countries.

Summary for Karyopharm Theraps

International Patents:	100
US Patents:	6
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Karyopharm Theraps

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-001	Jul 3, 2019		RX	Yes	No
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-002	Apr 15, 2021		RX	Yes	No	9,714,226		Y	Y
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-003	Apr 15, 2021		RX	Yes	No	9,079,865
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-003	Apr 15, 2021		RX	Yes	No	9,714,226		Y	Y
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-002	Apr 15, 2021		RX	Yes	No	8,999,996		Y	Y
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-001	Jul 3, 2019		RX	Yes	No
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-001	Jul 3, 2019		RX	Yes	No	10,544,108

International Patents for Karyopharm Theraps Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	3180331
Australia	2021286266
Japan	2018111713
Lithuania	2736887
Georgia, Republic of	P201706616
Canada	2842364
Australia	2012290454

Supplementary Protection Certificates for Karyopharm Theraps Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2736887	2021C/532	Belgium		PRODUCT NAME: SELINEXOR OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/21/1537 20210329
2736887	CA 2021 00031	Denmark		PRODUCT NAME: SELINEXOR ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1537 20210329
2736887	301119	Netherlands		PRODUCT NAME: SELINEXOR OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/21/1537 20210329
2736887	LUC00219	Luxembourg		PRODUCT NAME: SELINEXOR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/21/1537 20210329
2736887	122021000055	Germany		PRODUCT NAME: SELINEXOR ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1537 20210326
2736887	29/2021	Austria		PRODUCT NAME: SELINEXOR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1537 (MITTEILUNG) 20210329
2736887	PA2021007	Lithuania		PRODUCT NAME: SELINEKSORAS; REGISTRATION NO/DATE: EU/1/21/1537 20210326

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Karyopharm Theraps